The critical role of CD40/CD40L in the CD4-dependent generation of CD8+ T cell immunity

Journal of Leukocyte Biology

Volumn 67, Issue 5, 2000, Pages 607-614

  Clarke, S R M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Antigen presenting cell; CD4+ helper T cell; Costimulation; Cytokine; Cytotoxic T lymphocyte

Indexed keywords

CD4 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; CANCER CONTROL; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; ERADICATION THERAPY; HUMAN; HUMAN CELL; IMMUNIZATION; LIGAND BINDING; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

EID: 0033840544     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.67.5.607     Document Type: Review

References (105)

1. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo
2. + memory T cells
3. Counting antigen specific CD8 T cells: A reevaluation of bystander activation during viral infection
4. Immunological memory
5. Immunobiology of tissue transplantation: A return to the passenger leukocyte concept
6. The complexities of T-cell co-stimulation: CD28 and beyond
7. Cooperation between helper T cells and cytotoxic T lymphocyte precursors
8. A fail-safe mechanism for maintaining self-tolerance
9. + cells after a transient response to antigen
10. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes
11. a by exposure to alloantigen in the absence of T-cell help
12. Cooperation between cytotoxic and helper T lymphocytes in protection against lethal Sendal virus infection. Protection by T cells is MHC-restricted and MHC-regulated; a model for MHC-disease associations
13. CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CD8-positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/6 mice
14. Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus infected hepatocytes in vivo
15. + T cell help
16. Influence of strong CD4 epitope on long-term virus-specific cytotoxic T cell responses induced in vivo with peptides
17. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes
18. Induction of a CD8 cytotoxic T lymphocyte response by cross-priming requires cognate CD4 help
19. Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells
20. + T lymphocytes mediate clearance of virus and regulate the antiviral antibody response
21. + T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system
22. + T helper cell function in vivo: Differential requirement for induction of antiviral cytotoxic T-cell and antibody responses
23. + T cells
24. + cells but markedly decreased helper cell activity in mice lacking CD4
25. + T-cell-deficient mice
26. + T cells in cell-mediated immunity to LCMV: Studies in MHC class I and class II deficient mice
27. + cytotoxic T-cell responses during chronic viral infection
28. + T cells
29. Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice
30. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge
31. + T cells
32. Linked recognition of helper and cytotoxic antigenic determinants for the generation of cytotoxic T lymphocytes
33. Three-cell-type clusters of T cells with antigen-presenting cells best explain the epitope linkage and noncognate requirements of the in vivo cytolytic response
34. Helper effects required during in vivo priming for a cytolytic response to the H-Y antigen in nonresponder mice
35. + CTL in vivo with peptide vaccine constructs
36. Analysis of the role cf MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway
37. Induction of antitumor immunity using bone marrow-generated dendritic cells
38. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response
39. A new analysis of allogeneic interactions
40. Regulation of macrophage populations. I. Preferential induction of Ia-rich peritoneal exudates by immunologic stimuli
41. Concomitant induction of the cell surface expression of Ia determinants and accessory cell function by a murine macrophage tumor cell line
42. + T-cell responses
43. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
44. + T cells by B7-transfected melanoma cells
45. The many roles of CD40 in cell-mediated inflammatory responses
46. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes
47. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion
48. + T cells
49. Expression of a 32-kDa ligand for the CD40 antigen on activated human T lymphocytes
50. CD40 and its ligand in host defense
51. The role of CD40 ligand in costimulation and T-cell activation
52. The CD40-CD154 system in anti-infective host defense
53. CD40 ligation in B cell activation, isotype switching and memory development
54. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand
55. CD40 ligand-transduced co-stimulation of T cells in the development of helper function
56. CD40 and its crucial role as a member of the TNFR family
57. Regulation of expression of the ligand for CD40 on T helper lymphocytes
58. + T-cell responses
59. CD40 signaling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells
60. Activation of human dendritic cells through CD40 cross-linking
61. Induction of B cell costimulatory function by recombinant murine CD40 ligand
62. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downreguluted by tumor necrosis factor alpha
63. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes
64. Functional expression of CD40 antigen on human epidermal Langerhans cells
65. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
66. Identification of a costimulatory molecule rapidly induced by CD40L as CD44H
67. CD40L is important for induction of, but not response to, costimulatory activity. ICAM-1 as the second costimulatory molecule rapidly up-regulated by CD40L
68. CD40 ligand-dependent T cell activation, requirement of B7-CD28 signaling through CD40
69. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis
70. - T lymphocytes by 4-1BB ligand
71. CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40
72. + T cell contact-dependent activation of monocyte interleukin-1 synthesis
73. CD40 ligation induces lymphotoxin alpha gene expression in human B cells
74. Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells
75. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction
76. Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes
77. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages
78. High level IL-12 production by munne dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10
79. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal
80. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues
81. + CTL response
82. CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection
83. CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic ch0riomenlngitis virus
84. CD40 ligand-mediated interactions are involved in the generation of memory CD8(+) cytotoxic T lymphocytes (CTL) but are not required for the maintenance of CTL memory following virus infection
85. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
86. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay
87. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
88. CD40 ligand is a T cell growth factor
89. + T-helper and a T-killer cell
90. CD8(+) T cells mediate CD40-independent maturation of dendritic cells in vivo
91. + T cells to cause immunopathology
92. Microbial induction of co-stimulatory activity for CD4 T-cell growth
93. Effector T-cell induction and T-cell memory versus peripheral deletion oft cells
94. Cytotoxic T lymphocyte activation by cross-priming
95. + cytotoxic T lymphocytes in the absence of exogenous help
96. + T cells
97. + T cells in vitro
98. - T cells
99. IL-12 and viral infections
100. Disruption of CD154:CD40 blocks generation of allograft immunity without affecting APC activation
101. CD43 is a murine T cell costimulatory receptor that functions independently of CD28
102. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses
103. CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge
104. CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help
105. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy